Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 10, 2021

SELL
$4.55 - $6.72 $64,587 - $95,390
-14,195 Closed
0 $0
Q3 2020

Nov 09, 2020

BUY
$4.12 - $5.91 $50,243 - $72,072
12,195 Added 609.75%
14,195 $65,000
Q2 2020

Aug 05, 2020

BUY
$2.94 - $7.7 $5,880 - $15,400
2,000 New
2,000 $11,000

Others Institutions Holding AXLA

About Axcella Health Inc.


  • Ticker AXLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,500,896
  • Description
  • Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrenc...
More about AXLA
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.